☆ 4.6 Review

PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside

DIAGNOSTICS (2023)

Related references

Note: Only part of the references are listed.

Review Pathology

Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward

Luca Filippi et al.

Summary: Molecular neuroimaging with Tau-PET is an intriguing tool for the in vivo detection and monitoring of neuropathological hallmarks associated with CTE. Novel tracers, such as TSPO-ligands, hold promise for understanding the complex mechanisms leading from brain injury to symptomatic CTE.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2022)

Add to Collection

Article Clinical Neurology

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis

Aurelija Jucaite et al.

Summary: In this study, PET imaging of TSPO showed significantly increased binding in MSA patients, with machine learning improving sensitivity. Glia imaging may support clinical MSA diagnosis and patient stratification in clinical trials on novel drug therapies.

MOVEMENT DISORDERS (2022)

Add to Collection

Article Medicine, General & Internal

Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method

Yu-Hua Dean Fang et al.

Summary: A novel IDIF method for F-18-DPA-714 PET quantification was developed in this study, providing a noninvasive alternative measurement for arterial input function in the study of neuroinflammation and microglial activation. The results showed that this method accurately measures TSPO binding and demonstrates superior performance in distinguishing different binders.

DIAGNOSTICS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Recent developments on PET radiotracers for TSPO and their applications in neuroimaging

Lingling Zhang et al.

Summary: The 18 kDa translocator protein (TSPO) plays a key role in neuroinflammation and several TSPO-targeted PET tracers have been developed, some of which have advanced to clinical research studies.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Hybrid Imaging of Vascular Cognitive Impairment

Viviana Frantellizzi et al.

Summary: Cerebrovascular disease is a significant cause of cognitive impairment, different from Alzheimer's disease but with overlaps in risk factors, symptomatology, and treatment benefits. Vascular dementia is the most common cause of dementia after AD. Neuroimaging is essential for assessing vascular lesions in patients with cognitive decline and suspected VCID, and new hybrid devices offer potential for better differential diagnosis.

SEMINARS IN NUCLEAR MEDICINE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease

Viviana Frantellizzi et al.

Summary: The study found that the early Heart-to-Mediastinum count ratio is as accurate as traditional delayed imaging, reducing the differential diagnosis time for Parkinson's disease.

CURRENT RADIOPHARMACEUTICALS (2021)

Add to Collection

Article Neurosciences

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease

Christine Ghadery et al.

MOLECULAR NEUROBIOLOGY (2020)

Add to Collection

Review Neurosciences

Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review

Viviana Frantellizzi et al.

JOURNAL OF ALZHEIMERS DISEASE (2020)

Add to Collection

Article Clinical Neurology

Isolated head tremor: A DAT-SPECT and somatosensory temporal discrimination study

Gina Ferrazzano et al.

PARKINSONISM & RELATED DISORDERS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Translocator protein (TSPO): the new story of the old protein in neuroinflammation

Younghwan Lee et al.

BMB REPORTS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders

Eryn L. Werry et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding

Katarina Varnas et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

TSPO PET with [F-18]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis

Marcus Unterrainer et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Add to Collection

Article Immunology

Microglial activation in Parkinson's disease using [18F]-FEPPA

Christine Ghadery et al.

JOURNAL OF NEUROINFLAMMATION (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study

Tatsuhiro Terada et al.

ANNALS OF NUCLEAR MEDICINE (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Neuroinflammation: the devil is in the details

Damon J. DiSabato et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Add to Collection

Article Clinical Neurology

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease

Aurelija Jucaite et al.

BRAIN (2015)

Add to Collection

Article Multidisciplinary Sciences

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease

Yuko Koshimori et al.

PLOS ONE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Synthesis and Evaluation of Trans locator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971

Paolo Zanotti-Fregonara et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Add to Collection

Article Endocrinology & Metabolism

Determination of [11C]PBR28 binding potential in vivo: a first human TSPO blocking study

David R. Owen et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)

Add to Collection

Article Neurosciences

Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia

Paul Edison et al.

NEUROPSYCHOPHARMACOLOGY (2013)

Add to Collection

Article Clinical Neurology

In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease

S. Iannaccone et al.

PARKINSONISM & RELATED DISORDERS (2013)

Add to Collection

Article Clinical Neurology

Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes

Christopher Kobylecki et al.

PARKINSONISM & RELATED DISORDERS (2013)

Add to Collection

Article Clinical Neurology

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

G. D. Rabinovici et al.

NEUROLOGY (2007)

Add to Collection

Article Neurosciences

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

A Gerhard et al.

NEUROBIOLOGY OF DISEASE (2006)

Add to Collection

Article Clinical Neurology

Microglial activation and dopamine terminal loss in early Parkinson's disease

Y Ouchi et al.

ANNALS OF NEUROLOGY (2005)

Add to Collection

Article Clinical Neurology

Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [C-11]-CFT

JO Rinne et al.

ACTA NEUROLOGICA SCANDINAVICA (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.